Joanne Beck - Jun 7, 2022 Form 4 Insider Report for Orchard Therapeutics plc (ORTX)

Role
Director
Signature
/s/ Frank Thomas, as attorney-in-fact
Stock symbol
ORTX
Transactions as of
Jun 7, 2022
Transactions value $
$0
Form type
4
Date filed
6/8/2022, 04:06 PM
Previous filing
Jun 17, 2021
Next filing
Jun 21, 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORTX Stock Option (Right to Buy) Award $0 +46K $0.00 46K Jun 7, 2022 Ordinary Shares 46K $0.47 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All of the shares subject to this option vest upon the earlier to occur of June 7, 2023 or the date of the 2023 Annual General Meeting of the Company.
F2 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.